Table 2.
Patients With Spitz-Type Tumors and Sentinel Lymph Node Biopsies
| Sex/Age, y | Follow-up, mo | Location | Pathology Finding | SLNB | Additional Treatments | Statusa |
|---|---|---|---|---|---|---|
| F/40.0 | 117 | Abdomen | Combined lentiginous junctional dysplastic/desmoplastic Spitz nevus with severe atypia | Neg | None | Alive, NED |
| F/25.5 | 1 | L arm | Severely atypical spindle cell and epithelioid cell nevus (Spitz) | Neg | None | Alive, NED |
| M/15.7 | 2 | Mid back | Severely atypical compound Spitz nevus | Neg | None | Alive, NED |
| M/18.9 | 57 | R cheek | Atypical compound Spitz tumor | Neg | None | Alive, NED |
| F/67.2 | 106 | R upper thigh | Desmoplastic dermal Spitz nevus with atypia | Neg | None | Alive, NED |
| M/22.4 | 105 | L knee | Severely atypical Spitz tumor | Pos (1/3 L groin) | CLND (0/17 L groin) + IFN | Alive, NED |
Abbreviations: CLND, completion lymph node dissection; IFN, interferon; L, left; Mel, melanoma; NED, no evidence of disease; Neg, negative; Pos, positive; R, right; SLNB, sentinel lymph node biopsy finding.
a
No patient had developed melanoma by last follow-up.